References
1. Rummel K, Benson J, Roller L. Prostate adenocarcinoma with osteolytic
metastases: Case report and review of the literature. Radiol Case
Rep . 2021;16(11):3565-3568. doi:10.1016/j.radcr.2021.08.056
2. Idowu BM. Prostate carcinoma presenting with diffuse osteolytic
metastases and supraclavicular lymphadenopathy mimicking multiple
myeloma. Clin Case Rep . 2017;6(2):253-257. doi:10.1002/ccr3.1336
3. Cheville JC, Tindall D, Boelter C, et al. Metastatic prostate
carcinoma to bone: clinical and pathologic features associated with
cancer-specific survival. Cancer . 2002;95(5):1028-1036.
doi:10.1002/cncr.10788
4. Keller ET, Brown J. Prostate cancer bone metastases promote both
osteolytic and osteoblastic activity. J Cell Biochem .
2004;91(4):718-729. doi:10.1002/jcb.10662
5. Sottnik JL, Keller ET. Understanding and targeting osteoclastic
activity in prostate cancer bone metastases. Curr Mol Med .
2013;13(4):626-639. doi:10.2174/1566524011313040012